Health-Related Quality of Life, Perceived Social Support, and Depression in Disease-Free Survivors Who Underwent Curative Surgery Only for Prostate, Kidney and Bladder Cancer: Comparison among Survivors and with the General Population
0
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Purpose The purpose of this study was to compare health-related quality of life (HRQoL) of diseasefree prostate (PC), kidney (KC), and bladder cancer (BC) survivors with that of the general population. Materials and Methods Our study included 331 urological cancer (UC) survivors (114 PC, 108 KC, and 109 BC) aged 50 years disease-free for at least 1 year after surgery. The control group included 1,177 subjects without a history of cancer. The HRQoL was assessed using the European Organization for Research and Treatment of Cancer QLQ-C30, the Duke-UNC Functional Social Support Questionnaire, and the Patient Health Questionnaire-9. Results There was no significant difference between the groups in terms of any of the functioning sub-scales and symptoms, except significantly lower social functioning observed in BC survivors than that observed in KC survivors. Although the three groups of UC survivors showed essentially similar functioning sub-scales and symptoms when compared to the general population, PC and BC survivors showed significantly lower social functioning and a lower appetite than that observed in controls. KC survivors showed lower physical functioning, as well as higher pain and dyspnea. Although all three groups of UC survivors reported higher financial difficulties, they also reported higher perceived social support than that reported by the non-cancer control group. No statistically significant difference was observed in terms of depressive symptoms between each group of UC survivors and the general population. Conclusion Disease-free survivors of the three major types of UCs showed generally similar HRQoL compared to the general population, as well as compared to each other.
Abstract
Purpose The purpose of this study was to compare health-related quality of life (HRQoL) of diseasefree prostate (PC), kidney (KC), and bladder cancer (BC) survivors with that of the general population. Materials and Methods Our study included 331 urological cancer (UC) survivors (114 PC, 108 KC, and 109 BC) aged 50 years disease-free for at least 1 year after surgery. The control group included 1,177 subjects without a history of cancer. The HRQoL was assessed using the European Organization for Research and Treatment of Cancer QLQ-C30, the Duke-UNC Functional Social Support Questionnaire, and the Patient Health Questionnaire-9. Results There was no significant difference between the groups in terms of any of the functioning sub-scales and symptoms, except significantly lower social functioning observed in BC survivors than that observed in KC survivors. Although the three groups of UC survivors showed essentially similar functioning sub-scales and symptoms when compared to the general population, PC and BC survivors showed significantly lower social functioning and a lower appetite than that observed in controls. KC survivors showed lower physical functioning, as well as higher pain and dyspnea. Although all three groups of UC survivors reported higher financial difficulties, they also reported higher perceived social support than that reported by the non-cancer control group. No statistically significant difference was observed in terms of depressive symptoms between each group of UC survivors and the general population. Conclusion Disease-free survivors of the three major types of UCs showed generally similar HRQoL compared to the general population, as well as compared to each other.
참고문헌 (27)
- 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2014", Cancer Research and Treatment, 49(2), pp.292~305 (2017), 대한암학회
- 정재영, "Current Trends in the Incidence and Survival Rate of Urological Cancers in Korea", Cancer Research and Treatment, 49(3), pp.607~615 (2017), 대한암학회
- Siegel RL, "Cancer statistics, 2016", CA Cancer J Clin, 66, pp.7~30 (2016)
- Quaresma M, "40-year trends in an index of survival for all cancers combined and survival adjusted for age and sex for each cancer in England and Wales, 1971-2011 : a population-based study", Lancet, 385, pp.1206~1218 (2015)
- Miller KD, "Cancer treatment and survivorship statistics, 2016", CA Cancer J Clin, 66, pp.271~289 (2016)
- 김소연, "Public Perceptions on Cancer Incidence and Survival: A Nation-wide Survey in Korea", Cancer Research and Treatment, 48(2), pp.775~788 (2016), 대한암학회
- Yoo H, "Perceived social support and its impact on depression and health-related quality of life: a comparison between cancer patients and general population", Jpn J Clin Oncol, 47, pp.728~734 (2017)
- Aaronson NK, "The European Organization for Research and Treatment of Cancer QLQ-C30 : a quality-of-life instrument for use in international clinical trials in oncology", J Natl Cancer Inst, 85, pp.365~376 (1993)
- Yun YH, "Validation of the Korean version of the EORTC QLQ-C30", Qual Life Res, 13, pp.863~868 (2004)
- Broadhead WE, "The Duke-UNC Functional Social Support Questionnaire : measurement of social support in family medicine patients", Med Care, 26, pp.709~723 (1988)
- Suh SY, "A study for the development of Korean version of the Duke-UNC functional social support questionnaire", J Korean Acad Fam Med, 18, pp.250~260 (1997)
- Broadhead WE, "Social support and the cancer patient. Implications for future research and clinical care", Cancer, 67(3 Suppl), pp.794~799 (1991)
- Kroenke K, "The PHQ-9 : validity of a brief depression severity measure", J Gen Intern Med, 16, pp.606~613 (2001)
- Han C, "Validation of the Patient Health Questionnaire-9 Korean version in the elderly population : the Ansan Geriatric study", Compr Psychiatry, 49, pp.218~223 (2008)
- Stanton AL, "Life after diagnosis and treatment of cancer in adulthood : contributions from psychosocial oncology research", Am Psychol, 70, pp.159~174 (2015)
- Hara I, "Health-related quality of life after radical cystectomy for bladder cancer : a comparison of ileal conduit and orthotopic bladder replacement", BJU Int, 89, pp.10~13 (2002)
- Bestmann B, "Prostate-specific symptoms of prostate cancer in a German general population", Prostate Cancer Prostatic Dis, 10, pp.52~59 (2007)
- Parker WR, "Five year expanded prostate cancer index composite-based quality of life outcomes after prostatectomy for localized prostate cancer", BJU Int, 107, pp.585~590 (2011)
- Roth AJ, "Prostate cancer : psychosocial implications and management", Future Oncol, 4, pp.561~568 (2008)
- Prabhu V, "Short-, intermediate-, and long-term quality of life outcomes following radical prostatectomy for clinically localized prostate cancer", Rev Urol, 15, pp.161~177 (2013)
- Kent EE, "Health-related quality of life in older adult survivors of selected cancers : data from the SEER-MHOS linkage", Cancer, 121, pp.758~765 (2015)
- Beisland C, "Health-related quality of life in long-term survivors after renal cancer treatment", Scand J Urol, 48, pp.52~64 (2014)
- Lepore SJ, "Improving quality of life in men with prostate cancer : a randomized controlled trial of group education interventions", Health Psychol, 22, pp.443~452 (2003)
- Parahoo K, "Psychosocial interventions for men with prostate cancer : a Cochrane systematic review", BJU Int, 116, pp.174~183 (2015)
- Schroevers MJ, "The role of social support and self-esteem in the presence and course of depressive symptoms : a comparison of cancer patients and individuals from the general population", Soc Sci Med, 57, pp.375~385 (2003)
- Watts S, "Depression and anxiety in prostate cancer: a systematic review and meta-analysis of prevalence rates", BMJ Open, 4, pp.e003901~ (2014)
- 박보람, "The Prevalence of Depression among Patients with the Top Ten Most Common Cancers in South Korea", PSYCHIATRY INVESTIGATION, 14(5), pp.618~625 (2017), 대한신경정신의학회[DOI]